Newsfeeds - Spark Newswire

1 minute read

Antares Pharma Q3 EPS $0.03, Inline, Sales $48.19M Miss $48.33M Estimate

Today, 2:30 AM

Antares Pharma (NASDAQ:ATRS) reported quarterly earnings of $0.03 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $48.19

ATRS

32 minute read

Earnings Scheduled For November 4, 2021

By Benzinga Insights

Today, 2:30 AM

Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI

2 minute read

News

Overview Of Value Stocks In The Healthcare Sector

By Benzinga Insights

Today, 2:30 AM

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

ATRS

1 minute read

Lipocine, Antares Ink Licensing Pact For Testosterone Replacement Therapy In US

By Vandana Singh

Today, 2:30 AM

Lipocine Inc (NASDAQ:LPCN) has entered into an exclusive licensing agreement with Antares Pharma Inc (NASDAQ:ATRS) to commercialize Tlando in the U.S. Tlando is…

ATRS

2 minute read

FDA
News

Antares Pharma Initiates Phase I Study For ATRS-1902 For Adrenal Crisis Rescue

By Benzinga Newsdesk

Today, 2:30 AM

Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a specialty pharmaceutical company, today announced that it has initiated a Phase 1 study for ATRS-1902 for adrenal crisis rescue. The development program

ATRS

2 minute read

News

5 Value Stocks To Watch In The Healthcare Sector

By Benzinga Insights

Today, 2:30 AM

The Meaning Behind Value Stocks

AKUS

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

By Shanthi Rexaline

Today, 2:30 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

1 minute read

Antares Pharma Q2 EPS $0.03 Beats $0.01 Estimate, Sales $44.98M Beat $42.98M Estimate

By Benzinga Newsdesk

Today, 2:30 AM

Antares Pharma (NASDAQ:ATRS) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.01 by 200 percent. This is a 200 percent increase over earnings of $0.01 per share from the same

ATRS

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 2:30 AM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI